CN105685757A - Solid beverage for reducing hypertension, hyperglycemia and hyperlipidemia and making method thereof - Google Patents
Solid beverage for reducing hypertension, hyperglycemia and hyperlipidemia and making method thereof Download PDFInfo
- Publication number
- CN105685757A CN105685757A CN201610108388.6A CN201610108388A CN105685757A CN 105685757 A CN105685757 A CN 105685757A CN 201610108388 A CN201610108388 A CN 201610108388A CN 105685757 A CN105685757 A CN 105685757A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- extract
- hyperlipidemia
- hyperglycemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 30
- 235000013361 beverage Nutrition 0.000 title claims abstract description 29
- 201000001421 hyperglycemia Diseases 0.000 title claims abstract description 29
- 239000007787 solid Substances 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 23
- 206010020772 Hypertension Diseases 0.000 title abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 37
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 34
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 27
- 241000894006 Bacteria Species 0.000 claims abstract description 24
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 18
- 239000011575 calcium Substances 0.000 claims abstract description 18
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 17
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000011718 vitamin C Substances 0.000 claims abstract description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 16
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 16
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 16
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 16
- 239000004310 lactic acid Substances 0.000 claims abstract description 15
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 15
- 239000000395 magnesium oxide Substances 0.000 claims abstract description 14
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 14
- 229960003067 cystine Drugs 0.000 claims abstract description 13
- 235000020712 soy bean extract Nutrition 0.000 claims abstract description 13
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 12
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 11
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 11
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 11
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 11
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 11
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 11
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 11
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 11
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 11
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 11
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 10
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 20
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 20
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 17
- 238000012216 screening Methods 0.000 claims description 17
- 230000003276 anti-hypertensive effect Effects 0.000 claims description 15
- 239000008187 granular material Substances 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 13
- 241000195474 Sargassum Species 0.000 claims description 12
- 235000013399 edible fruits Nutrition 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 12
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 11
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 11
- 239000011230 binding agent Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 238000011084 recovery Methods 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 16
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract description 15
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 10
- 229940011671 vitamin b6 Drugs 0.000 abstract description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract description 7
- 230000036772 blood pressure Effects 0.000 abstract description 7
- 239000008103 glucose Substances 0.000 abstract description 7
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract description 7
- 235000019158 vitamin B6 Nutrition 0.000 abstract description 7
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract description 6
- 229960002477 riboflavin Drugs 0.000 abstract description 6
- 229930003471 Vitamin B2 Natural products 0.000 abstract description 5
- 235000019164 vitamin B2 Nutrition 0.000 abstract description 5
- 229930003451 Vitamin B1 Natural products 0.000 abstract description 3
- 229930003779 Vitamin B12 Natural products 0.000 abstract description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract description 3
- 229960003495 thiamine Drugs 0.000 abstract description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract description 3
- 235000010374 vitamin B1 Nutrition 0.000 abstract description 3
- 235000019163 vitamin B12 Nutrition 0.000 abstract description 3
- 240000005979 Hordeum vulgare Species 0.000 abstract description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract description 2
- 240000007594 Oryza sativa Species 0.000 abstract description 2
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 2
- 241000193830 Bacillus <bacterium> Species 0.000 abstract 1
- 235000019393 L-cystine Nutrition 0.000 abstract 1
- 239000004158 L-cystine Substances 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 239000005988 Sea-algae extract (formerly sea-algae extract and seaweeds) Substances 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- 235000009566 rice Nutrition 0.000 abstract 1
- 229940029079 rose petal extract Drugs 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 241001092040 Crataegus Species 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000011664 nicotinic acid Substances 0.000 description 5
- 235000001968 nicotinic acid Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 101710167605 Spike glycoprotein Proteins 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 229940011871 estrogen Drugs 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 229940086319 nattokinase Drugs 0.000 description 3
- 108010073682 nattokinase Proteins 0.000 description 3
- 235000013557 nattō Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- CHWVDGYLKPLBES-UHFFFAOYSA-N 5-(2-methoxyphenyl)-2-furoic acid Chemical group COC1=CC=CC=C1C1=CC=C(C(O)=O)O1 CHWVDGYLKPLBES-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030247 Oestrogen deficiency Diseases 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 125000003929 folic acid group Chemical group 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001504664 Crossocheilus latius Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000208204 Linum Species 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- QDOXWKRWXJOMAK-UHFFFAOYSA-N dichromium trioxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 230000037345 metabolism of vitamins Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000012459 muffins Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- -1 phosphate ester Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical group 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
- A23L2/395—Dry compositions in a particular shape or form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention belongs to a solid beverage for reducing the hypertension, hyperglycemia and hyperlipidemia and a making method thereof. The solid beverage is characterized by being made from, by weight, 100-300 parts of sea algae extract, 150-200 parts of rose petal extract, 190-200 parts of dietary fiber, 30-100 parts of matcha, 20-60 parts of barley seedling powder, 15-50 parts of hawthorn powder, 1-10 parts of lactic acid bacteria, 5-10 parts of rice bran, 5-10 parts of soybean extract, 5-10 parts of bacillus yeast, 3-9 parts of bacillus natto culture extract, 10-30 parts of magnesium oxide, 3-10 parts of vitamin C, 3-9 parts of L-cystine, 3-9 parts of nicotinamide, 3-9 parts of calcium, 1-3 parts of vitamin B6, 0.5-1 part of vitamin B2, 0.5-1 part of vitamin B1 and 0.005-0.01 part of vitamin B12. The solid beverage has obvious effects on preventing the hypertension, hyperglycemia and hyperlipidemia, has remarkable effects on reducing blood pressure, glucose level and blood fat for people suffering from the hypertension, hyperglycemia and hyperlipidemia, and can keep the effects.
Description
Technical field
The invention belongs to solid beverage, particularly to a kind of antihypertensive, hyperglycemia, hyperlipidemia solid beverage and manufacture method thereof。
Background technology
The unhealthy living habit that current living environment brings, as unhealthy diet, physical exertion reduce and various social factor, makes the people of " three high " also get more and more。Three-hypers is exactly the general name of hypertension, hyperglycemia, hyperlipidemia, is the arch-criminal of cardiovascular and cerebrovascular disease, the health of the serious harm mankind。
Hypertension: refer to that in human recycle system, blood pressure, higher than normal, is that systemic arterial pressure increases the clinical syndrome for principal phenomena, its serious being detrimental to health, even result in death。
Hyperglycemia: refer to that human organism's Glucose in Blood by Cyclic is higher than normal value。In body, a self-existent islet cells characteristic of disease changes, and lesion nature is dysglycemia。It causes each histoorgan generation pathological changes of whole body, causes acute and chronic complication。Even if such as resistance decline, impaired renal function, retinopathy, cardiovascular and diabetes etc.。
Hyperlipidemia: referring to blood cholesterol or triglyceride is excessive or high content lipoprotein cholesterol is too low, present medical science is referred to as dyslipidemia。It is to cause the aorta indeclinable principal element of medicated porridge sample, is the risk factors that appear and develop of cardiovascular and cerebrovascular vessel。Incidence of occult, does not have clinical symptom mostly。
Summary of the invention
It is an object of the invention to a kind of antihypertensive, hyperglycemia, hyperlipidemia solid beverage and manufacture method thereof how to prevent " three high " that the people of existing three-hypers symptom is suppressed by diet。
This invention address that technical problem be the technical scheme is that a kind of antihypertensive, hyperglycemia, hyperlipidemia solid beverage, it is characterized in that, by weight: Sargassum extract 100 ~ 300 parts, Flos Rosae Rugosae petal extract 150 ~ 200 parts, dietary fiber 190 ~ 200 parts, matcha 30 ~ 100 parts, 20 ~ 60 parts of Herba Hordei Vulgaris powder, hawthorn fruit 15 ~ 50 parts, lactic acid bacteria 4 ~ 10 parts, 5 ~ 10 parts of Testa oryzae, soybean extract 5 ~ 10 parts, bean bacterium fermented product 5 ~ 10 parts, Bacillus natto cultivates extract 3 ~ 9 parts, magnesium oxide 10 ~ 30 parts, vitamin C 3 ~ 10 parts, CYSTINE 3 ~ 9 parts, nicotiamide 3 ~ 9 parts, calcium 3 ~ 9 parts, vitamin B61 ~ 3 part, vitamin B20.5 ~ 1 part, vitamin B10.5 ~ 1 part, vitamin B120.005 ~ 0.01 part。
A kind of hypertension, hyperglycemia, hyperlipidemia solid beverage manufacture method, it is characterised in that take following steps:
A. by Sargassum extract 100 ~ 300 parts, Flos Rosae Rugosae petal extract 150 ~ 200 parts, dietary fiber 190 ~ 200 parts, matcha 30 ~ 100 parts, 20 ~ 60 parts of Herba Hordei Vulgaris powder, hawthorn fruit 15 ~ 50 parts, lactic acid bacteria 4 ~ 10 parts, 5 ~ 10 parts of Testa oryzae, soybean extract 5 ~ 10 parts, bean bacterium fermented product 5 ~ 10 parts, Bacillus natto cultivates extract 3 ~ 9 parts, magnesium oxide 10 ~ 30 parts, vitamin C 3 ~ 10 parts, CYSTINE 3 ~ 9 parts, nicotiamide 3 ~ 9 parts, calcium 3 ~ 9 parts, vitamin B61 ~ 3 part, vitamin B20.5 ~ 1 part, vitamin B10.5 ~ 1 part, vitamin B120.005 ~ 0.01 part, add stirring in blender, whipping process send the warm air of 45 ° of c in blender;Stir 30 ~ 40 minutes uniformly till;
B. going out grain: the raw material stirred is loaded pelletize in comminutor, granulation process send the hot blast of 90 ° of C in pelletize cabinet, and sprays polyvinylpyrrolidone (PVP) binding agent in raw material, and the amount of polyvinylpyrrolidone (PVP) binding agent is the 2.5% of raw material;
C. screening: being installed to by the solid beverage choosing granule in screening machine and screen, the sieve in screening machine is 30 orders, and will through being provided with 10000 Gauss Magnetitums filtrations;More than the granule of 30 orders, recovery is delivered to and is carried out in disintegrating machine being broken into below 30 orders, enters back into packer intermediate package;
D. the antihypertensive of the 30 following granules of order, hyperglycemia, hyperlipidemia solid beverage being sent into packer intermediate package, packaging adopts paper tinsel bag, every bag of 5g;
E. the pouch of 5g/ bag is sent into and banding machine carries out bale packing vanning。
The invention has the beneficial effects as follows: this invention has the effect of obvious prophylaxis of hypertension, hyperglycemia and hyperlipidemia, people's blood pressure lowering of existing " three high ", blood sugar lowering, lipid-lowering effect significantly, and can be maintained。
Accompanying drawing explanation
Below in conjunction with accompanying drawing, illustrate with embodiment。
Fig. 1 be a kind of antihypertensive, hyperglycemia, hyperlipidemia solid beverage cause method flow block diagram;
In Fig. 1: 1-blender;2-comminutor;3-screening machine;4-packer;5-banding machine;6-disintegrating machine。
Detailed description of the invention
Embodiment one, with reference to accompanying drawing, a kind of antihypertensive, hyperglycemia, hyperlipidemia solid beverage, it is characterised in that, by weight: Sargassum extract 100 parts, Flos Rosae Rugosae petal extract 150 parts, dietary fiber 190 parts, matcha 30 parts, 20 parts of Herba Hordei Vulgaris powder, hawthorn fruit 15 parts, lactic acid bacteria 4 parts, 5 parts of Testa oryzae, soybean extract 5 parts, bean bacterium fermented product 5 parts, Bacillus natto cultivates extract 3 parts, magnesium oxide 10 parts, vitamin C 3 parts, CYSTINE 3 parts, nicotiamide 3 parts, calcium 3 parts, vitamin B61 part, vitamin B20.5 part, vitamin B10.5 part, vitamin B120.005 part。
A kind of hypertension, hyperglycemia, hyperlipidemia solid beverage manufacture method, it is characterised in that take following steps:
A. Sargassum extract 100 parts, Flos Rosae Rugosae petal extract 150 parts, dietary fiber 190 parts, matcha 30 parts, 20 parts of Herba Hordei Vulgaris powder, hawthorn fruit 15 parts, lactic acid bacteria 4 parts, 5 parts of Testa oryzae, soybean extract 5 parts, bean bacterium fermented product 5 parts, Bacillus natto cultivates extract 3 parts, magnesium oxide 10 parts, vitamin C 3 parts, CYSTINE 3 parts, nicotiamide 3 parts, calcium 3 parts, vitamin B61 part, vitamin B20.5 part, vitamin B10.5 part, vitamin B120.005 part, add stirring in blender 1, whipping process send the warm air of 45 ° of c in blender;Stir 30 minutes uniformly till;
B. grain is gone out: the raw material stirred is loaded pelletize in comminutor 2; granulation process send the hot blast of 90 ° of C in pelletize cabinet; and in raw material, spray polyvinylpyrrolidone (PVP) binding agent, the amount of polyvinylpyrrolidone (PVP) binding agent is the 2.5% of raw material;
C. screening: being installed to by the solid beverage choosing granule in screening machine and screen, the sieve in screening machine 3 is 30 orders, and will through being provided with 10000 Gauss Magnetitums filtrations;More than the granule of 30 orders, recovery is delivered to and is carried out in disintegrating machine 6 being broken into below 30 orders, enters back into packer 4 intermediate package;
D. the antihypertensive of the 30 following granules of order, hyperglycemia, hyperlipidemia solid beverage being sent into packer 4 intermediate package, packaging adopts aluminum pipe bag, every bag of 5g;
E. the pouch of 5g/ bag is sent into and banding machine 5 carries out bale packing vanning。
Embodiment two, with reference to accompanying drawing, a kind of antihypertensive, hyperglycemia, hyperlipidemia solid beverage, it is characterized in that, by weight: Sargassum extract 200 parts, Flos Rosae Rugosae petal extract 175 parts, dietary fiber 195 parts, matcha 65 parts, 40 parts of Herba Hordei Vulgaris powder, hawthorn fruit 32.5 parts, lactic acid bacteria 7 parts, 7.5 parts of Testa oryzae, soybean extract 7.5 parts, bean bacterium fermented product 7.5 parts, Bacillus natto cultivates extract 6 parts, magnesium oxide 20 parts, vitamin C 6.5 parts, CYSTINE 6 parts, nicotiamide 6 parts, calcium 6 parts, vitamin B6 2 parts, vitamin B2 0.75 part, vitaminB10 .75 part, vitamin B12 0.075 part。
A kind of hypertension, hyperglycemia, hyperlipidemia solid beverage manufacture method, it is characterised in that take following steps:
A. Sargassum extract 200 parts, Flos Rosae Rugosae petal extract 175 parts, dietary fiber 195 parts, matcha 65 parts, 40 parts of Herba Hordei Vulgaris powder, hawthorn fruit 32.5 parts, lactic acid bacteria 7 parts, 7.5 parts of Testa oryzae, soybean extract 7.5 parts, bean bacterium fermented product 7.5 parts, Bacillus natto cultivates extract 6 parts, magnesium oxide 20 parts, vitamin C 6.5 parts, CYSTINE 6 parts, nicotiamide 6 parts, calcium 6 parts, vitamin B62 parts, vitamin B20.75 part, vitamin B10.75 part, vitamin B120.075 part, add stirring in blender 1, whipping process send the warm air of 45 ° of c in blender;Stir 35 minutes uniformly till;
B. grain is gone out: the raw material stirred is loaded pelletize in comminutor 2; granulation process send the hot blast of 90 ° of C in pelletize cabinet; and in raw material, spray polyvinylpyrrolidone (PVP) binding agent, the amount of polyvinylpyrrolidone (PVP) binding agent is the 2.5% of raw material;
C. screening: being installed to by the solid beverage choosing granule in screening machine and screen, the sieve in screening machine 3 is 30 orders, and will through being provided with 10000 Gauss Magnetitums filtrations;More than the granule of 30 orders, recovery is delivered to and is carried out in disintegrating machine 6 being broken into below 30 orders, enters back into packer 4 intermediate package;
D. the antihypertensive of the 30 following granules of order, hyperglycemia, hyperlipidemia solid beverage being sent into packer 4 intermediate package, packaging adopts aluminum pipe bag, every bag of 5g;
E. the pouch of 5g/ bag is sent into and banding machine 5 carries out bale packing vanning。
Embodiment three, with reference to accompanying drawing, a kind of antihypertensive, hyperglycemia, hyperlipidemia solid beverage, it is characterised in that, by weight: Sargassum extract 300 parts, Flos Rosae Rugosae petal extract 200 parts, dietary fiber 200 parts, matcha 100 parts, 60 parts of Herba Hordei Vulgaris powder, hawthorn fruit 50 parts, lactic acid bacteria 10 parts, 10 parts of Testa oryzae, soybean extract 10 parts, bean bacterium fermented product 10 parts, Bacillus natto cultivates extract 9 parts, magnesium oxide 30 parts, vitamin C 10 parts, CYSTINE 9 parts, nicotiamide 9 parts, calcium 9 parts, vitamin B63 parts, vitamin B21 part, vitamin B11 part, vitamin B120.01 part。
A kind of hypertension, hyperglycemia, hyperlipidemia solid beverage manufacture method, it is characterised in that take following steps:
A. Sargassum extract 300 parts, Flos Rosae Rugosae petal extract 200 parts, dietary fiber 200 parts, matcha 100 parts, 60 parts of Herba Hordei Vulgaris powder, hawthorn fruit 50 parts, lactic acid bacteria 10 parts, 10 parts of Testa oryzae, soybean extract 10 parts, bean bacterium fermented product 10 parts, Bacillus natto cultivates extract 9 parts, magnesium oxide 30 parts, vitamin C 10 parts, CYSTINE 9 parts, nicotiamide 9 parts, calcium 9 parts, vitamin B63 parts, vitamin B21 part, vitamin B11 part, vitamin B120.01 part, add stirring in blender 1, whipping process send the warm air of 45 ° of c in blender;Stir 40 minutes uniformly till;
B. going out grain: the raw material stirred is loaded pelletize in comminutor, granulation process send the hot blast of 90 ° of C in pelletize cabinet, and sprays polyvinylpyrrolidone (PVP) binding agent in raw material, and the amount of polyvinylpyrrolidone (PVP) binding agent is the 2.5% of raw material;
C. screening: being installed to by the solid beverage choosing granule in screening machine and screen, the sieve in screening machine is 30 orders, and will through being provided with 10000 Gauss Magnetitums filtrations;More than the granule of 30 orders, recovery is delivered to and is carried out in disintegrating machine being broken into below 30 orders, enters back into packer intermediate package;
D. the antihypertensive of the 30 following granules of order, hyperglycemia, hyperlipidemia solid beverage being sent into packer intermediate package, packaging adopts aluminum pipe bag, every bag of 5g;
E. the pouch of 5g/ bag is sent into and banding machine carries out bale packing vanning。
Described linseed meal: also known as big linum, is found that three kinds of very important fatty acids: Omega-6, Omega-3 and Omega-9 in pure natural plant Semen Lini。These three fatty acid is one of most basic nutrient of wanting of needed by human body, and wherein Omega-3 and Omega-6 is that human body itself cannot produce。Semen Lini (powder) has health care, gives protection against cancer, cuts the multinomial effect such as fertilizer, cholesterol reducing。Can being applied directly in bread or muffin, or be added in Yoghourt or cereals, gruel, bean milk, milk etc., multiple collocation is selected by you。
Described corn starch: also known as corn starch, popular name NLIUGU powder;The white flaxen powder of micro-strip;After corn field 0.3% sulfurous acid is impregnated, made by operations such as crushing, sieve, precipitate, dry, be levigate。Containing a small amount of fat and protein。Suction temperature is strong, is up to more than 30%, is mainly used in aminoacid medicine, food processing, medicated beer, papermaking etc.。Chemical formula: (C6H1005) n。
Described matcha: " matcha " is the powder being utilized stone grinder to wear into by " stone roller tea ", and its particle diameter is generally 1~20 micron of ten thousand/centimetre, and most particle diameter is below 3 microns, in micronizing。Matcha (Matcha) powder contains nutritional labeling and trace element necessary to abundant human body, it is mainly composed of tea polyphenols, caffeine, free amino acid, chlorophyll, protein, aromatic substance, cellulose, vitamin C, A, B1, B2, B3, B5, B6, E, K, H etc., and trace elements K, calcium, magnesium, ferrum, sodium, zinc, selenium, fluorine etc. nearly more than 30 are planted。
Described Herba Hordei Vulgaris powder: also known as Herba Hordei Vulgaris powder。Barley young leaf green juice contains the protein of about 30%, exceedes all vegetables, and its protein is small molecule structure, is different from milk, the macromolecular structure of meat etc., is more favorable for absorption of human body。The various natural amino acids of constitutive protein matter are also conducive to accelerating metabolism, have good effect for pre-preventing obesity。Herba Hordei Vulgaris powder is base-forming food, containing abundant dietary fiber, vitamin, trace element, particularly with hundreds of organized enzyme, human body cell is played an important role。
Described Sargassum extract: Sargassum contains a kind of special protein and is called parent's glycoprotein, certain sugars is had an affinity and Non-covalent binding with it by it。Parent's glycoprotein and cell membrane glycan molecule can cause cell settlement phenomenon after combining, and are therefore a kind of agglutinins。Parent's glycoprotein is prevalent in land animals and plants and microorganism, especially enriches especially in seeds of leguminous plant。The characteristic of parent's its identification saccharide of glycoprotein mat, plays an important role on biological defence, growth, reproduction, nutrition storage and biocenosis。Parent's glycoprotein also apply be applicable to blood cell separation detection, on pharmaceutical carrier, the generation of immune antibody and the medical usage of cancer therapy drug。
Described Flos Rosae Rugosae petal extract: Flos Rosae Rugosae, it is flavor of raw material famous in the world, and people's its smoked tea multiplex, alcoholic and the various sweet food product of preparation, it is worth often also high than gold。Flos Rosae Rugosae is used as medicine, and it spends shady dry, has circulation of qi promoting, invigorates blood circulation, astriction, and in fruit, Vitamin C content is significantly high, is the raw material extracting natural complex C。By the aromatic oil of quirk, for fine perfumery。Flower is used as medicine, function vital energy regualting and blood circulation-promoting, dispersing the stagnated live-QI to relieve the stagnation of QI, cures mainly the diseases such as stomachache due to hyperactive liver-QI attacking the stomach, lack of appetite vomiting and nausea, menoxenia, stable damage。
Described Testa oryzae: also known as Oryza glutinosa, average containing protein 15%, fat 16%-22% in Testa oryzae, sugar 3%-8%, moisture 10%, heat is approximately 125.1KJ/g。Fatty acid main in fat be mostly oleic acid,Linoleic acidDengUnsaturated fatty acid, and containing a large amount vitamin,Pohytol、Dietary fiber, aminoacid and mineral etc.。Its action effect: relieving constipation, reduction cholesterol, minimizing urinary stone, anticancer skin-protection and health-care etc. acts on。
Described soybean extract: soybean extract is the one form of which of vegetalization compound。Its molecular weight and structure are all similar to human body estrogen, so also referred to as plant estrogen。For the too high person of estrogen, there is the impact of harm reduction;For estrogen deficiency person, can supplement again to relax the phenomenon of estrogen deficiency。According to clinical studies show, soybean isoflavone has multiple health benefits, including improving menopause syndrome, improve climacteric osteoporosis, reducing the function such as cardiovascular disease and antioxidation。
Described fermenting bacillus natto thing: Bacillus natto, another name Bafillus natt (Bacillusnatto), belong to bacillus subtilis Bacillus natto subspecies (for gram positive bacteria, aerobic, have spore, very easily chaining。Bacillus natto, is generally (0.7-0.8) μ m (2.0-3.0) μm, Gram-positive。It is grown in the cellular plasm even dyeing of agar glucose。Spore ellipse or column, middle life or raw in partially, even if sporangiocyst expands, also notable, amphitrichous, can move。Growth temperature highest order 45-55 DEG C is minimum for 5-20 DEG C。Spore thermostability is strong。
Described Bacillus natto cultivates extract: have another name called nattokinase;Nattokinase (nattokinase is called for short NK) is a kind of Proteinkinase, is a kind of serine protease produced by Bacillus subtilis natto from Traditional Japanese Food (Bacillussubtilislnatto) in soybean isoflavone by natto strain。There is thrombus, reduce blood viscosity, improve the effects such as blood circulation, softening and increase blood vessel elasticity。Within 1980, being found in natto, be made up of according to stationary arrangement mode 275 aminoacid, molecular weight is 27724, has the unique function decomposing thrombosis, and active effect represents with intrinsic unit FU。
Described magnesium oxide: another name magnesia;Lamp powder;Magnesia usta, white fine-powder。Odorlessness。Because preparation method is different, have lightweight and heavy point。Strong refraction is had in visible and near-ultraviolet range。Dew be empty in gas easily absorb moisture andDioxy Change carbonAnd be increasingly becomingBasic magnesium carbonate, lightweight heavier faster, is combined generation with waterMagnesium hydroxide, react in alkalescence, the pH10.3 of saturated aqueous solution。But poleReadily solubleIn diluted acid, atomic it is dissolved in pure water, increases its dissolubility 852 DEG C, boiling point 3600 DEG C because of the existence of carbon dioxide。Application: for food additive, tint stabilizer, pH value regulator as the supplement of health product, the magnesium elements of food。It is used as the decolorising agent dried ice cream mix PH regulator etc. when Saccharum Sinensis Roxb. is refined。It is used for the fields such as wheat flour, milk powder chocolate, cocoa powder, grape fruit powder, Icing Sugar as anti-caking agent and antacid。Chemical formula (MgO)。
Described vitamin C: vitamin C (VitaminC, AscorbicAcid) be again L-AA, is a kind of water solublityVitamin,FruitWithVegetableMiddle rich content。Playing regulatory role in redox metabolism reacts, lacking it can causeVitamin C deficiency。Under normal circumstances, the vitamin C overwhelming majority becomes oxalic acid through metabolic breakdown in vivo or is combined generation ascorbic acid-2-sulphuric acid with sulphuric acid by urine ejection, and another part can be directly external by urine ejection, molecular formula (C6H8O6)。
Described dietary fiber: dietary fiber refers to the polysaccharide and lignin that can not be decomposed by human body alimentary canal ferment。It mostlys come from vegeto-animal cell wall, including cellulose, lignin, wax, chitin, pectin, beta glucan, inulin and oligosaccharide etc.。Dietary fiber is that health diet is indispensable, absorbs enough fibers and can prevent cardiovascular disease, cancer, diabetes and Other diseases;Cleaning wall of digestive, strengthen digestive function, dilute and the removing of the carcinogen that adds in food and noxious substance, digestive tract that protection is fragile and preventing colon cancer, slows down digestion rate, rapid drainage cholesterol。So the blood glucose in blood and cholesterol can be allowed to control in optimal level。
Described Fructus Crataegi extracts powder: Fructus Crataegi extracts dry mature fruit (containing the core) extract that powder is rosaceous plant Fructus Crataegi。It has an enhancing myocardial contraction, increases cardiac output, decreasing heart rate, increases coronary flow, reduces myocardial oxygen consumption and cardiac muscle coefficient of oxygen utilization, prevents or alleviates myocardial ischemia or necrosis that isoproterenol causes, myocardial ischemia has good protective effect;Meanwhile, Fructus Crataegi ethanol extract has more lasting hypotensive effect;Additionally, the various hyperlipidemia models that different animals is caused by different extraction parts have effect for reducing fat relatively certainly。
Described lactic acid bacteria: every antibacterial that can produce lactic acid in the sweat of glucose or lactose is referred to as lactic acid bacteria。This is the antibacterial that a group is quite numerous and jumbled, at least can be divided into 18 genus at present, have kind more than 200。Outside depolarization minority, wherein the overwhelming majority is all requisite in human body and has the flora of important physiological function, and it is widely present in the intestinal of human body, and enteral lactic acid bacteria and good health and a long life have very close relationship。
Described CYSTINE: CYSTINE is to be found from vesical calculus by Wollaston for 1810。It is a kind of sulfur-containing amino acid, has a small amount of existence, be contained in the keratin of hair, paw etc. more in protein。For biochemistry and nutrient research, melanic formation, enhancing body cellular oxidation and reduction function can be suppressed, increase leukocyte and stop the effects such as pathogen growth。
Described nicotinic acid, nicotinic acid is also referred to as vitamin B3 (molecular formula: C6H5NO), and it is one of 13 kinds of vitamin of needed by human。Nicotinic acid has a stronger expansion peripheral vessels effect, participates in the process of HypercholesterolemicRats, the oxidizing process of Tissue respiration and saccharide anaerobic decomposition。Nicotinic acid can facilitating digestion, alleviate gastrointestinal disorders and make skin more healthy, prevention is gentle solves serious migraine, and blood circulation promoting makes blood pressure drops alleviating diarrhoea phenomenon。
Described calcium: calcium is a kind of metallic element, symbol Ca is positioned at the 4th cycle, group iia in the periodic table of chemical element, and be silvery white in color under room temperature crystal。The skeleton of animal, Concha Meretricis Seu Cyclinae, eggshell all contain calcium carbonate。Calcium enjoys the title of " biological element ", and within 20 years old, later women is especially needed supplementary。Calcium deficiency is the big factor causing female aging, therefore replenishes the calcium women is the most important。Adult women at least absorbs 1000 milligrams of calcium every day。If in period of pregnancy, age of sucking or menopause, then must add to 1500 milligrams。
So-called vitamin B6: also known as pyridoxin, exist with the form of phosphate ester in vivo, is a kind of water soluble vitamins。The constituent of vitamin B6 behaviour some coenzyme internal, participates in multiple metabolic response, especially has substantial connection with amino acid metabolism。Vitamin B6 is body fat and glycometabolic required material, and the estrogen metabolism of women is also required to vitamin B6, and therefore it benefits to preventing and treating some gynaecopathia。
So-called vitamin B2: be again riboflavin (chemical formula: C17H20N4O6), for the ingredient of internal yellow enzymes prothetic group。The storage of internal vitamin B2 is very limited, therefore will supply every day。Vitamin B2 participates in vivo biodistribution oxidation and energy metabolism, can improve the human body utilization rate to protein, enhancing development, safeguard the integrity of skin and cell membrane;Participate in the growth metabolism of cell, be the necessary nutrient of when injected organism tissue metabolism and reparation, such as strengthening liver function, regulate adrenergic secretion;Participate in the metabolism of vitamin B6 and nicotinic acid, be a model of vitamin B group coordinative role;Additionally, also have antioxidant activity。
Described vitamin B1: the same with the vitamin in all B races, unnecessary B1 will not be stored in internal, and can be completely exhausted out external, so must supplement every day。Vitamin B1 promotes the metabolism of saccharide in vivo, helps digest, fatigue alleviating;Participate in there is synergism between vitamin B group。
Described vitamin B12: for one of vitamin B group, is the class complex organic compound containing cobalt。It can promote erythrocytic growth and maturation, makes human body hematopoietic function be in normal condition, prevents pernicious anemia;Safeguard that nervous system is healthy;The utilization rate of folic acid can be increased, promote the metabolism of carbohydrate, fat and protein;There is the effect of activated amino acid and promote to promote the synthesis of protein by the biosynthesis of nucleic acid;Fat metabolism acid, makes fat, carbohydrate, protein suitably be used by health;Eliminate dysphoria, focus on, hypermnesis and equilibrium sense。
This invention is it was verified that on SOD(ferment in human body) impact, the colleague playing antioxidation, in inductor, SOD produces, and increases its activity。
Starting blood pressure after hypertension is quoted surrounding to be controlled, high pressure started to drop from 14 days, and 200 can drop to 180, and are maintained。Hyperglycemia is quoted 6 days and just significantly decrease, dropped to 200 by 350, and the generation of diabetes and complication can be suppressed。Hyperlipidemia neutral fat is down to 100 by 200, and is suppressed。
Instructions of taking: take after mixing it with water with the boiled water of 100 ° of C degree, takes secondary, each 5g day。
The actual effect of this invention can be illustrated by following three patients:
Case 1:
Huang, man, hyperglycemia, hyperlipidemia, hyperpietic, taking compositions provided by the invention through recommendation, take continuously 26 days, T-CHOL 7.32mmol/L drops to 4.23mmol/L, triglyceride 2.6mmol/L drops to 0.93mmol/L, blood pressure 145/97mmHg drops to 128/80mmHg, and blood glucose drops to 5.7mmol/L from 12.5mmol/L, and all indexs all return to normal value。
Case 2:
Zou, man, hyperglycemia, hyperlipidemia, hyperpietic, compositions provided by the invention is taken through recommendation, taking continuously 35 days, T-CHOL 7.32mmol/L drops to 4.23mmol/L, and triglyceride 3.4mmol/L drops to 0.93mmol/L, blood pressure 145/97mmHg drops to 128/80mmHg, and blood glucose drops to 5.7mmol/L from 12.5mmol/L
Case 3:
Poplar, Patients with Cardiovascular/Cerebrovascular Diseases, compositions provided by the invention is taken through recommendation, taking continuously 30 days, triglyceride drops to 1.14mmol/L from 5.94mmol/L, and the data exceeded standard in the past all return to regime values, and cardiac symptom is substantially alleviated, not breathing heavily upstairs, bow not dizzy, condition is good。
Claims (2)
1. an antihypertensive, hyperglycemia, hyperlipidemia solid beverage, it is characterized in that, by weight: Sargassum extract 100-300 part, Flos Rosae Rugosae petal extract 150-200 part, dietary fiber 190-200 part, matcha 30-100 part, Herba Hordei Vulgaris powder 20-60 part, hawthorn fruit 15-50 part, lactic acid bacteria 1-10 part, Testa oryzae 5-10 part, soybean extract 5-10 part, bean bacterium fermented product 5-10 part, Bacillus natto cultivates extract 3-9 part, magnesium oxide 10-30 part, vitamin C 3-10 part, CYSTINE 3-9 part, nicotiamide 3-9 part, calcium 3-9 part, vitamin B61-3 part, vitamin B20.5-1 part, vitamin B10.5-1 part, vitamin B120.005-0.01 part。
2. a kind of antihypertensive according to claim 1, hyperglycemia, hyperlipidemia solid beverage and manufacture method thereof;It is characterized in that taking following steps:
A. by Sargassum extract 100-300 part, Flos Rosae Rugosae petal extract 150-200 part, dietary fiber 190-200 part, matcha 30-100 part, Herba Hordei Vulgaris powder 20-60 part, hawthorn fruit 15-50 part, lactic acid bacteria 1-10 part, Testa oryzae 5-10 part, soybean extract 5-10 part, bean bacterium fermented product 5-10 part, Bacillus natto cultivates extract 3-9 part, magnesium oxide 10-30 part, vitamin C 3-100 part, CYSTINE 3-9 part, nicotiamide 3-9 part, calcium 3-9 part, vitamin B61-3 part, vitamin B20.5-1 part, vitamin B10.5-1 part, vitamin B120.005-0.01 part adds stirring in blender (1), send the warm air of 45 ° of c in whipping process in blender (1);Stir 30 ~ 40 minutes uniformly till;
B. grain is gone out: the raw material stirred is loaded pelletize in comminutor (2); granulation process send the hot blast of 90 ° of C in pelletize cabinet; and in raw material, spray polyvinylpyrrolidone (PVP) binding agent, the amount of polyvinylpyrrolidone (PVP) binding agent is the 2.5% of raw material;
C. screening: the solid beverage choosing granule installs to screening in screening machine (3), and the sieve in screening machine (3) is 30 orders, and will through being provided with 10000 Gauss Magnetitums filtrations;More than the granule of 30 orders, recovery is delivered in disintegrating machine (6) and is carried out being broken into below 30 orders, enters back into packer (4) intermediate package;
D. the antihypertensive of the 30 following granules of order, hyperglycemia, hyperlipidemia solid beverage being sent into packer (4) intermediate package, packaging adopts aluminum pipe bag, every bag of 5g;
E. the pouch of 5g/ bag is sent into and banding machine (5) carries out bale packing vanning。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610108388.6A CN105685757A (en) | 2016-02-29 | 2016-02-29 | Solid beverage for reducing hypertension, hyperglycemia and hyperlipidemia and making method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610108388.6A CN105685757A (en) | 2016-02-29 | 2016-02-29 | Solid beverage for reducing hypertension, hyperglycemia and hyperlipidemia and making method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105685757A true CN105685757A (en) | 2016-06-22 |
Family
ID=56223489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610108388.6A Pending CN105685757A (en) | 2016-02-29 | 2016-02-29 | Solid beverage for reducing hypertension, hyperglycemia and hyperlipidemia and making method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105685757A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106261380A (en) * | 2016-08-16 | 2017-01-04 | 安徽省王巢食品有限公司 | A kind of healthcare rose flower beverage and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104543811A (en) * | 2013-10-21 | 2015-04-29 | 广州博能生物科技有限公司 | Natural composite powder for improving immunity and preparation method and application of natural composite powder |
CN104839698A (en) * | 2015-04-23 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Cardiovascular disease non-total nutrient formula food |
-
2016
- 2016-02-29 CN CN201610108388.6A patent/CN105685757A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104543811A (en) * | 2013-10-21 | 2015-04-29 | 广州博能生物科技有限公司 | Natural composite powder for improving immunity and preparation method and application of natural composite powder |
CN104839698A (en) * | 2015-04-23 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Cardiovascular disease non-total nutrient formula food |
Non-Patent Citations (7)
Title |
---|
PEI-YING LIN ET AL: "《Hypertension, hyperglycemia, and hyperlipemia among adolescents with intellectual disabilities》", 《RESEARCH IN DEVELOPMENTAL DISABILITIES》 * |
南朝君: "《食疗、营养与烹调》", 31 January 2014, 北京:中国医药科技出版社 * |
孙德海等: "《易混淆中药鉴别》", 31 July 2015, 北京:中国医药科技出版社 * |
崔洪斌等: "《大豆生物活性物质研究应用进展》", 31 August 2001, 北京:华文出版社 * |
李基洪: "《软饮料生产工艺与配方3000例 上册》", 31 January 2004, 广州:广东科技出版社 * |
汪多仁: "《绿色医药化学品》", 31 July 2008, 北京:科学技术文献出版社 * |
马祥志等: "《有机化学第四版》", 31 July 2014, 北京:中国医药科技出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106261380A (en) * | 2016-08-16 | 2017-01-04 | 安徽省王巢食品有限公司 | A kind of healthcare rose flower beverage and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103027231B (en) | Compound probiotics fermented Chinese herbal medicine active health care liquid and preparation method thereof | |
CN108272073A (en) | A kind of weight losing meal-replacing powder and preparation method thereof | |
CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
CN102524659A (en) | Grain formula with nutrition and health care functions | |
CN102524408A (en) | Nutritious soybean milk and preparation method thereof | |
CN107048131A (en) | Vegetable Drink Fermented and preparation method thereof | |
CN107568736A (en) | Dealcoholic sobering-up medical science formula food | |
CN103549078A (en) | Toxin-expelling and slimming tea and preparation method thereof | |
CN108308468A (en) | A kind of dendrobium candidum enzyme beverage and preparation method thereof with defaecation, stomach-nourishing function | |
CN104304560A (en) | Sweet tea kombucha | |
CN101953413A (en) | Fig natural face-nourishing and weight-losing cold herbal tea and preparation method thereof | |
KR100922252B1 (en) | Method of lactic-acid fermented substitute food | |
CN103734421A (en) | Liver-benefiting kidney-tonifying stomach-invigorating tea and preparation method thereof | |
CN106819854A (en) | A kind of barley young leaf composite powder and preparation method thereof | |
CN104304578A (en) | Pitaya fungus tea | |
CN106418525A (en) | Fermenting folium mori chewable tablet and preparation method thereof | |
CN104382129A (en) | Beverage prepared from sweet corn and black tea fungus | |
CN104351900A (en) | Biological type drink taking glutinous rice as raw material, and preparation of biological type drink | |
CN104287039A (en) | Biological beverage prepared from brown rice and preparation method thereof | |
CN106235318A (en) | The method preparing ferment for primary raw material with Flos Lonicerae, Rhizoma Curcumae Longae | |
CN103404852A (en) | Functional compound natto health care product | |
CN109170863A (en) | A kind of functional sugar ferment and preparation method thereof | |
CN102511876B (en) | Hawthorn red jujube thick syrup and production process thereof | |
CN104305429A (en) | Fermentation type okra tea drink | |
CN104286280A (en) | Pawpaw and red tea fungus drink |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160622 |